Royal Philips has announced the launch of its intuitive interventional guidance platform, IntraSight Plus, which is cleared for clinical use in the USA and Europe.
The redesigned platform combines the most comprehensive diagnostic and treatment planning tools to deliver efficiency, simplicity and precision in a single intuitive system, the company says in a press release, enabling clinicians to diagnose, virtually plan treatment, guide device placement and verify results on a single screen.
“As more advanced technology is integrated into the cath lab, the need for connectivity between the imaging tools is more important than ever before,” said Stacy Beske, business leader, Image Guided Therapy Devices at Philips. “IntraSight Plus was built using feedback from our customers and represents a fundamental shift in interventional cardiology—a future driven by integrated intelligence that lets physicians focus on the decision-making that only they can do.”
On March 19, Jan-Malte Sinning performed the first patient case using IntraSight Plus at Cellitinnen-Krankenhaus St Vinzenz in Köln, Germany. The hospital recently renewed its cath lab infrastructure with Philips’ Azurion interventional suites. The addition of IntraSight Plus as part of this ecosystem allows for enhanced physician workflow, Philips says in a press release.
“Modern PCI is becoming increasingly complex,” said Sinning. “Intravascular imaging combined with physiology provides the level of detail we need for contemporary PCI. What stands out with IntraSight Plus is that the platform is clearly designed around how we actually work in the cath lab—combining physiology, imaging and decision-making support in a way that fits naturally into the clinical workflow.”
The patient treated in this first case presented with an acute ST-elevation myocardial infarction (STEMI) of the left anterior descending (LAD) artery two days ago and underlying complex three-vessel disease. Using the Philips Azurion interventional platform in combination with the new IntraSight Plus system, Sinning performed a complete revascularisation prior to discharge.
The integrated tri-registration of angiography, physiological assessment, and intravascular imaging enabled a streamlined and intuitive workflow, allowing treatment to be focused on haemodynamically relevant lesions and ensuring optimal stent deployment to improve patient outcomes.
Merging Philips’ IntraSight and SyncVision technologies, IntraSight Plus brings class IA intravascular ultrasound (IVUS) and instantaneous wave-free ratio/fractional flow reserve (iFR/FFR) physiology, co-registration, tri-registration and real-time device visualisation together in one system.
